Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard O'Callaghan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Procedures

Microbial Colony Count

Anatomy

Chemicals & Drugs

Concepts & Ideas

Virulence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
38
Hill, James
27
Hobden, Jeffery
22
Caballero, Armando
22
Dajcs, Joseph
22
Engel, Lee
20
Marquart, Mary
18
Thibodeaux, Brett
17
Moreau, Judy
14
Girgis, Dalia
9
Hume, Emma
9
Sloop, Gregory
8
McCormick, Clare
8
Reed, Julian
7
Green, LC
6
Cannon, Bennetta

Sign-in to see all Coauthors

Publications

TOP 3
Tang Aihua; Marquart Mary E; Fratkin Jonathan D; McCormick Clare C; Caballero Armando R; Gatlin Hattie P; O'Callaghan Richard J
Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions.
McCormick Clare C; Caballero Armando R; Balzli Charles L; Tang Aihua; O'Callaghan Richard J
Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus.
McCormick Clare; Caballero Armando; Tang Aihua; Balzli Charles; Song Jenny; O'Callaghan Richard
Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard O'Callaghan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tang Aihua; Marquart Mary E; Fratkin Jonathan D; McCormick Clare C; Caballero Armando R; Gatlin Hattie P; O'Callaghan Richard J
Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions.
Investigative ophthalmology & visual science 2009;50(8):3794-801.
2009: McCormick Clare C; Caballero Armando R; Balzli Charles L; Tang Aihua; O'Callaghan Richard J
Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus.
Investigative ophthalmology & visual science 2009;50(6):2848-54.
2008: McCormick Clare; Caballero Armando; Tang Aihua; Balzli Charles; Song Jenny; O'Callaghan Richard
Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
Current medical research and opinion 2008;24(6):1569-75.
2008: Balzli Charles L; McCormick Clare C; Caballero Armando R; Huang Bo; Wigington Laura; Smith Emily; Tang Aihua; O'Callaghan Richard J
Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Journal of cataract and refractive surgery 2008;34(2):295-301.
2008: Green Sherrina N; Sanders Melissa; Moore Quincy C; Norcross Erin W; Monds Kathryn S; Caballero Armando R; McDaniel Larry S; Robinson Sherrina A; Onwubiko Chinwendu; O'Callaghan Richard J; Marquart Mary E
Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.
Investigative ophthalmology & visual science 2008;49(1):290-4.
2007: O'Callaghan Richard J; McCormick Clare C; Caballero Armando R; Marquart Mary E; Gatlin Hattie P; Fratkin Jonathan D
Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
Investigative ophthalmology & visual science 2007;48(11):5125-31.
2007: McCormick C C; Hobden J A; Balzli C L; Reed J M; Caballero A R; Denard B S; Tang A; O'Callaghan R J
Surfactant protein D in Pseudomonas aeruginosa keratitis.
Ocular immunology and inflammation 2007;15(5):371-9.
2007: Marquart Mary E; Monds Kathryn S; McCormick Clare C; Dixon Sherrina N; Sanders Melissa E; Reed Julian M; McDaniel Larry S; Caballero Armando R; O'Callaghan Richard J
Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.
Investigative ophthalmology & visual science 2007;48(6):2661-6.
2007: Thibodeaux Brett A; Caballero Armando R; Marquart Mary E; Tommassen Jan; O'Callaghan Richard J
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Current eye research 2007;32(4):373-86.
2006: McCormick Clare C; Dajcs Joseph J; Reed Julian M; Marquart Mary E; O'Callaghan Richard J
The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
Current eye research 2006;31(3):225-30.
2006: Caballero Armando R; Marquart M E; O'Callaghan Richard J; Thibodeaux B A; Johnston K H; Dajcs J J
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Current eye research 2006;31(1):23-9.
2005: Marquart Mary E; Caballero Armando R; Chomnawang Mullika; Thibodeaux Brett A; Twining Sally S; O'Callaghan Richard J
Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
Investigative ophthalmology & visual science 2005;46(10):3761-8.
2005: Girgis Dalia O; Sloop Gregory D; Reed Julian M; O'Callaghan Richard J
Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Investigative ophthalmology & visual science 2005;46(6):2064-70.
2005: Thibodeaux Brett A; Caballero Armando R; Dajcs Joseph J; Marquart Mary E; Engel Lee S; O'Callaghan Richard J
Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
Ocular immunology and inflammation 2005;13(2-3):169-82.
2005: Girgis Dalia O; Reed Julian M; Monds Kathryn S; Dajcs Joseph J; Marquart Mary E; Thibodeaux Brett A; O'Callaghan Richard J
Pathogenesis of Staphylococcus in the rabbit anterior chamber.
Investigative ophthalmology & visual science 2005;46(4):1371-8.
2005: Reed Julian M; O'Callaghan Richard J; Girgis Dalia O; McCormick Clare C; Caballero Armando R; Marquart Mary E
Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
Investigative ophthalmology & visual science 2005;46(2):604-8.
2005: Malloy Jaret L; Veldhuizen Ruud A W; Thibodeaux Brett A; O'Callaghan Richard J; Wright Jo Rae
Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.
American journal of physiology. Lung cellular and molecular physiology 2005;288(2):L409-18.
2005: Marquart Mary E; Dajcs Joseph J; Caballero Armando R; Thibodeaux Brett A; O'Callaghan Richard J
Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.
Medical microbiology and immunology 2005;194(1-2):39-45.
2004: Girgis Dalia O; Sloop Gregory D; Reed Julian M; O'Callaghan Richard J
Susceptibility of aged mice to Staphylococcus aureus keratitis.
Current eye research 2004;29(4-5):269-75.
2004: Dajcs Joseph J; Thibodeaux Brett A; Marquart Mary E; Girgis Dalia O; Traidej Mullika; O'Callaghan Richard J
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Antimicrobial agents and chemotherapy 2004;48(6):1948-52.
2004: Thibodeaux Brett A; Dajcs Joseph J; Caballero Armando R; Marquart Mary E; Girgis Dalia O; O'Callaghan Richard J
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Current eye research 2004;28(5):337-42.
2004: Caballero Armando; Thibodeaux Brett; Marquart Mary; Traidej Mullika; O'Callaghan Richard
Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases.
Investigative ophthalmology & visual science 2004;45(2):522-30.
2003: O'Callaghan Richard J; Girgis Dalia O; Dajcs Joseph J; Sloop Gregory D
Host defense against bacterial keratitis.
Ocular immunology and inflammation 2003;11(3):171-81.
2003: Girgis Dalia O; Sloop Gregory D; Reed Julian M; O'Callaghan Richard J
A new topical model of Staphylococcus corneal infection in the mouse.
Investigative ophthalmology & visual science 2003;44(4):1591-7.
2003: Girgis Dalia O; Dajcs Joseph J; O'Callaghan Richard J
Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes.
Investigative ophthalmology & visual science 2003;44(1):197-202.
2003: Traidej Mullika; Caballero Armando R; Marquart Mary E; Thibodeaux Brett A; O'Callaghan Richard J
Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida.
Investigative ophthalmology & visual science 2003;44(1):190-6.
2003: Traidej Mullika; Marquart Mary E; Caballero Armando R; Thibodeaux Brett A; O'Callaghan Richard J
Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation.
The Journal of biological chemistry 2003;278(4):2549-53.
2002: Dajcs Joseph J; Thibodeaux Brett A; Girgis Dalia O; Shaffer Megan D; Delvisco Stephen M; O'Callaghan Richard J
Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Investigative ophthalmology & visual science 2002;43(12):3712-6.
2002: Moreau Judy M; Conerly Lisa L; Hume Emma B H; Dajcs Joseph J; Girgis Dalia O; Cannon Bennetta M; Thibodeaux Brett A; Stroman David W; O'Callaghan Richard J
Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
Cornea 2002;21(8):807-11.
2002: Dajcs Joseph J; Thibodeaux Brett A; Girgis Dalia O; O'Callaghan Richard J
Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
DNA and cell biology 2002;21(5-6):375-82.
2002: Dajcs Joseph J; Austin Megan S; Sloop Gregory D; Moreau Judy M; Hume Emma B H; Thompson Hilary W; McAleese Fionnuala M; Foster Timothy J; O'Callaghan Richard J
Corneal pathogenesis of Staphylococcus aureus strain Newman.
Investigative ophthalmology & visual science 2002;43(4):1109-15.
2001: Hume E B; Dajcs J J; Moreau J M; Sloop G D; Willcox M D; O'Callaghan R J
Staphylococcus corneal virulence in a new topical model of infection.
Investigative ophthalmology & visual science 2001;42(12):2904-8.
2001: Dajcs J J; Moreau J M; Thibodeaux B A; Traidej M; Austin M S; Marquart M E; Stroman D W; O'Callaghan R J
Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Cornea 2001;20(8):878-80.
2001: Moreau J M; Girgis D O; Hume E B; Dajcs J J; Austin M S; O'Callaghan R J
Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus.
Investigative ophthalmology & visual science 2001;42(10):2347-54.
2001: White C D; Alionte L G; Cannon B M; Caballero A R; O'Callaghan R J; Hobden J A
Corneal virulence of LasA protease--deficient Pseudomonas aeruginosa PAO1.
Cornea 2001;20(6):643-6.
2001: Dajcs J J; Moreau J M; Stroman D W; Schlech B A; Ke T L; Thibodeaux B A; Girgis D O; Caballero A R; O'Callaghan R J
The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Current eye research 2001;23(1):60-3.
2001: Dajcs J J; Thibodeaux B A; Hume E B; Zheng X; Sloop G D; O'Callaghan R J
Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
Current eye research 2001;22(6):451-7.
2001: Alionte L G; Cannon B M; White C D; Caballero A R; O'Callaghan R J; Hobden J A
Pseudomonas aeruginosa LasA protease and corneal infections.
Current eye research 2001;22(4):266-71.
2001: Caballero A R; Moreau J M; Engel L S; Marquart M E; Hill J M; O'Callaghan R J
Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases.
Analytical biochemistry 2001;290(2):330-7.
2000: Hume E B; Dajcs J J; Moreau J M; O'Callaghan R J
Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.
Infection and immunity 2000;68(10):6052-5.
2000: Balaban N; Collins L V; Cullor J S; Hume E B; Medina-Acosta E; Vieira da Motta O; O'Callaghan R; Rossitto P V; Shirtliff M E; Serafim da Silveira L; Tarkowski A; Torres J V
Prevention of diseases caused by Staphylococcus aureus using the peptide RIP.
Peptides 2000;21(9):1301-11.
2000: Dajcs J J; Hume E B; Moreau J M; Caballero A R; Cannon B M; O'Callaghan R J
Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Investigative ophthalmology & visual science 2000;41(6):1432-7.
1999: Hume E B; Conerly L L; Moreau J M; Cannon B M; Engel L S; Stroman D W; Hill J M; O'Callaghan R J
Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits.
Current eye research 1999;19(6):525-32.
1999: Zheng X; Marquart M E; Loustch J M; Shah P; Sainz B; Ray A; O'Callaghan R J; Kaufman H E; Hill J M
HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Investigative ophthalmology & visual science 1999;40(11):2490-7.
1999: O'Callaghan R J
Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998.
Cornea 1999;18(5):532-7.
1999: Hume E B; Moreau J M; Conerly L L; Cannon B M; Dajcs J J; Hill J M; O'Callaghan R J
Clarithromycin for experimental Staphylococcus aureus keratitis.
Current eye research 1999;18(5):358-62.
1999: Sloop G D; Moreau J M; Conerly L L; Dajcs J J; O'Callaghan R J
Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit.
Investigative ophthalmology & visual science 1999;40(2):385-91.
1998: Moreau J M; Green L C; Engel L S; Hill J M; O'Callaghan R J
Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Current eye research 1998;17(8):808-12.
1998: Engel L S; Hill J M; Caballero A R; Green L C; O'Callaghan R J
Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa.
The Journal of biological chemistry 1998;273(27):16792-7.
1998: Engel L S; Hill J M; Moreau J M; Green L C; Hobden J A; O'Callaghan R J
Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Investigative ophthalmology & visual science 1998;39(3):662-5.
1997: Moreau J M; Sloop G D; Engel L S; Hill J M; O'Callaghan R J
Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas.
Current eye research 1997;16(12):1221-8.
1997: Engel L S; Hobden J A; Moreau J M; Callegan M C; Hill J M; O'Callaghan R J
Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
Investigative ophthalmology & visual science 1997;38(8):1535-42.
1997: Hill J M; Garza H H; Helmy M F; Cook S D; Osborne P A; Johnson E M; Thompson H W; Green L C; O'Callaghan R J; Gebhardt B M
Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits.
Journal of neurovirology 1997;3(3):206-11.
1997: O'Callaghan R J; Callegan M C; Moreau J M; Green L C; Foster T J; Hartford O M; Engel L S; Hill J M
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection.
Infection and immunity 1997;65(5):1571-8.
1996: Hill J M; Gebhardt B M; Wen R; Bouterie A M; Thompson H W; O'Callaghan R J; Halford W P; Kaufman H E
Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency.
Journal of virology 1996;70(5):3137-41.
1996: O'Callaghan R J; Engel L S; Hobden J A; Callegan M C; Green L C; Hill J M
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
Investigative ophthalmology & visual science 1996;37(4):534-43.
1996: Engel L S; Callegan M C; Hill J M; Folkens A T; Shimomura Y; O'Callaghan R J
The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Japanese journal of ophthalmology 1996;40(2):212-9.
1996: Green L C; Callegan M C; Engel L S; Shimomura Y; Jasheway D W; O'Callaghan R J; Hill J M
Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
Japanese journal of ophthalmology 1996;40(1):123-6.
1995: Johnson M K; Callegan M C; Engel L S; O'Callaghan R J; Hill J M; Hobden J A; Boulnois G J; Andrew P W; Mitchell T J
Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea.
Current eye research 1995;14(4):281-4.
1995: Engel L S; Callegan M C; Hobden J A; Reidy J J; Hill J M; O'Callaghan R J
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Current eye research 1995;14(3):229-34.
1994: Callegan M C; Engel L S; Clinch T E; Hill J M; Kaufman H E; O'Callaghan R J
Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
Current eye research 1994;13(12):875-8.
1994: Callegan M C; O'Callaghan R J; Hill J M
Pharmacokinetic considerations in the treatment of bacterial keratitis.
Clinical pharmacokinetics 1994;27(2):129-49.
1994: Callegan M C; Engel L S; Hill J M; O'Callaghan R J
Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.
Infection and immunity 1994;62(6):2478-82.
1994: Callegan M C; Engel L S; Hill J M; O'Callaghan R J
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Investigative ophthalmology & visual science 1994;35(3):1033-7.
1993: Hobden J A; Hill J M; Engel L S; O'Callaghan R J
Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
Antimicrobial agents and chemotherapy 1993;37(9):1856-9.
1993: Hobden J A; Engel L S; Hill J M; Callegan M C; O'Callaghan R J
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.
Current eye research 1993;12(5):469-73.
1993: Hobden J A; Engel L S; Callegan M C; Hill J M; Gebhardt B M; O'Callaghan R J
Pseudomonas aeruginosa keratitis in leukopenic rabbits.
Current eye research 1993;12(5):461-7.
1993: Hobden J A; O'Callaghan R J; Insler M S; Hill J M
Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis.
Cornea 1993;12(2):138-41.
1993: Engel L S; Callegan M C; Hill J M; O'Callaghan R J
Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor.
Journal of ocular pharmacology 1993;9(4):311-20.
1992: Johnson M K; Hobden J A; O'Callaghan R J; Hill J M
Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Current eye research 1992;11(12):1221-5.
1992: Callegan M C; Hill J M; Insler M S; Hobden J A; O'Callaghan R J
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Current eye research 1992;11(11):1111-9.
1992: Clinch T E; Hobden J A; Hill J M; O'Callaghan R J; Engel L S; Kaufmann H E
Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc 1992;18(4):245-7.
1992: Callegan M C; Hobden J A; Hill J M; Insler M S; O'Callaghan R J
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Investigative ophthalmology & visual science 1992;33(11):3017-23.
1992: Hobden J A; O'Callaghan R J; Hill J M; Hagenah M; Insler M S; Reidy J J
Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
Current eye research 1992;11(3):259-65.
1992: Brockman E B; Tarantino P A; Hobden J A; Hill J M; O'Callaghan R J; Kaufman H E; Insler M S
Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Refractive & corneal surgery 1992;8(1):39-43.
1991: Insler M S; Fish L A; Silbernagel J; Hobden J A; O'Callaghan R J; Hill J M
Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin.
Ophthalmology 1991;98(11):1690-2.
1991: Reidy J J; Hobden J A; Hill J M; Forman K; O'Callaghan R J
The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Cornea 1991;10(1):25-8.
1990: Hobden J A; Reidy J J; O'Callaghan R J; Insler M S; Hill J M
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Investigative ophthalmology & visual science 1990;31(11):2241-3.
1990: Johnson M K; Hobden J A; Hagenah M; O'Callaghan R J; Hill J M; Chen S
The role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Current eye research 1990;9(11):1107-14.
1990: Hobden J A; Reidy J J; O'Callaghan R J; Insler M S; Hill J M
Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.
Investigative ophthalmology & visual science 1990;31(10):1940-4.
1989: Hobden J A; O'Callaghan R J; Hill J M; Reidy J J; Rootman D S; Thompson H W
Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
Current eye research 1989;8(11):1163-9.
1988: Hobden J A; Reidy J J; O'Callaghan R J; Hill J M; Insler M S; Rootman D S
Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
Archives of ophthalmology 1988;106(11):1605-7.
1988: Hobden J A; Rootman D S; O'Callaghan R J; Hill J M
Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.
Antimicrobial agents and chemotherapy 1988;32(7):978-81.
1988: Rootman D S; Hobden J A; Jantzen J A; Gonzalez J R; O'Callaghan R J; Hill J M
Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
Archives of ophthalmology 1988;106(2):262-5.

Sign-in to see more